27 November 2024
Newsletter September 2024
Summary of Newsletter September 2024: Message from President VIPOC Fourth…
27 November 2024
Newsletter June 2024
Summary of Newsletter June 2024: Message from President World Vitiligo…
21 October 2024
Incyte Announces Health Canada Approval of OPZELURA® (ruxolitinib) Cream for the Treatment of Atopic Dermatitis (AD) and Nonsegmental Vitiligo
News provided by Incyte Biosciences Canada - First and only…
5 July 2024
World Vitiligo Day 2024 Highlights
We are thrilled to announce that World Vitiligo Day was…
3 July 2024
Vitiligo recognised as a disease in D.R. Congo
The Provincial Minister of Health of Haut-Katanga (Democratic Republic of…
27 March 2024
Tacrolimus 0.1% approved for vitiligo treatment
The French National Agency for the Safety of Medicines has…
24 March 2024
New Expert Recommendations on Pediatric Vitiligo Care
By the way, have you seen this? The first-ever US…
